Skip to content
JournalsWorldThe Global Research Discovery Platform
Login Sign Up

Academic Journal

Q3

Future Science OA

Taylor and Francis Ltd.

United KingdomBiotechnology (Q3); Medicine (miscellaneous) (Q3)ISSN-matched source record
Submission information ↗
Q3Ranking
—Impact Factor (year unverified)
52H-index (SCImago 2025)
0.506SJR (2025)
2015-2026Coverage

About Future Science OA

Future Science OA is a scholarly journal published by Taylor and Francis Ltd.. SCImago 2025 lists it in Q3, with an SJR of 0.506 and H-index of 52.

Coverage: 2015-2026. Research categories: Biotechnology (Q3); Medicine (miscellaneous) (Q3).

Open-access policies and author information

Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2024-08-13. This snapshot does not establish today’s listing status or fee quotation.

Accepted manuscript languagesEnglish
Licence optionsCC BY-NC
Peer-review processDouble anonymous peer review
APCDOAJ-reported APC: 1440 GBP
Waiver policy reportedYes
Other fees reportedNo
Author retains unrestricted copyrightNo
Digital preservationCLOCKSS, LOCKSS, Portico
Reported submission-to-publication time13 weeks on average; not a guarantee
Openly licensed content since2015 (not the journal founding year)

Publisher policy links recorded by DOAJ

Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.

Source-backed journal facts

ISSN(s)2056-5623
ISSN-L2056-5623
Source typeJournal
Publisher / hosting organisationFuture Science Ltd
Publisher country codeGB
Fully open access (OpenAlex)Yes
DOAJ flag (OpenAlex)Listed in OpenAlex metadata; confirm current status in DOAJ
Works recorded in OpenAlex1,203
Citations recorded in OpenAlex17,464
OpenAlex H-index62
Years represented in OpenAlex1974–2026 (not the founding or closing dates)

Topics in published research

Computational Drug Discovery Methods; Cancer Immunotherapy and Biomarkers; 3D Printing in Biomedical Research; COVID-19 Clinical Research Studies; Mesenchymal stem cell research; Inflammatory Biomarkers in Disease Prognosis.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit